home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

The 2015 Controlling Cancer Summit

 
  June 02, 2014  
     
 


EuroSciCon, Cineworld: The O2 Peninsula Square London London SE10 0DX United Kingdom
Tuesday, 12 May 2015 09:00 - Thursday, 14 May 2015 17:00


With plenty of opportunity  for networking and debate, this informal international  meeting will bring you up to date with current research and thinking regarding cancer screening, prevention and treatment.  Presenters will include Clinicians, Academics and members of the Pharmaceutical industry and we encourage presentations from  the wide spectrum of cancer research, development and healthcare professionals.  

This event  has CPD accreditation

Who Should Attend
The conference is open to academics, clinicians and industrial partners creating a stimulating environment in which to promote lively discussion, productive collaboration and innovation. 

 

This will be a paperless meeting, please print out the agenda before you come or download the pdf onto your computer or smartphone.  

Pdfs of our agendas can be found at http://lifescienceevents.com/events 
 
 
Organized by: Euroscicon
Invited Speakers:
Talks include:

ErbB-targeted CAR T-cell immunotherapy of cancer: a strategy to maximize the window of therapeutic opportunity.

Dr John Maher, Senior Lecturer in Immunology, NIHR Biomedical Research Centre at Guy¹s and St Thomas¹ NHS Foundation, Trust and King¹s College London, Research Oncology, Division of Cancer Studies, Guy's Hospital campus, St Thomas St, London, United Kingdom

Current status of minimally invasive diagnosis and staging of lung malignancies
Dr Jorge Pascual, MD, Assistant Professor, Mayo Clinic College of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Florida, USA

Overcoming Mechanisms of Therapeutic Resistance in Advanced Castration Resistant Prostate Cancer
Dr Natasha Kyprianou, James F. Hardymon Chair in Urology Research, Professor of Urology, Molecular Biochemistry, Pathology and Toxicology, Combs, Rm 306, University of Kentucky College of Medicine, Lexington, KY, US

Breast Cancer, Chemo-resistance and ErbB receptors
Professor Zhixiang Wang, PhD, Department of Medical Genetics, Signal Transduction Research Group, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
 
 
Deadline for Abstracts: The Deadline for abstract submissions for oral presentation is Feb 10th 2015
 
Registration: Click here to register
E-mail: enquiries@euroscicon.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.